DocSym
β
Searchsearch
Search
(D56.9) Thalassaemia, unspecified
More details coming soon
20 434 in individuals diagnosis thalassaemia, unspecified confirmed
3 007 deaths with diagnosis thalassaemia, unspecified
15% mortality rate associated with the disease thalassaemia, unspecified
Diagnosis thalassaemia, unspecified is diagnosed Women are 1.40% more likely than Men
10 074
Men receive the diagnosis thalassaemia, unspecified
1 039 (10.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
10 360
Women receive the diagnosis thalassaemia, unspecified
1 968 (19.0 %)Died from this diagnosis.
Risk Group for the Disease thalassaemia, unspecified - Men aged 30-34 and Women aged 5-9
In Men diagnosis is most often set at age 0-19, 25-54, 60-64, 75-89
Less common in men the disease occurs at Age 20-24, 55-59, 65-74, 90-95+Less common in women the disease occurs at Age 40-44, 70-74, 90-95+
In Women diagnosis is most often set at age 0-39, 45-69, 75-89
Disease Features thalassaemia, unspecified
Absence or low individual and public risk
Thalassaemia, unspecified - what does this mean
Thalassaemia is an inherited blood disorder caused by a defect in the production of haemoglobin, the oxygen-carrying protein in red blood cells. it is characterised by an abnormal production of red blood cells, resulting in anemia, fatigue, and other symptoms. it is usually inherited in an autosomal recessive pattern, meaning that both parents must be carriers of the gene to pass it on to their children.
What happens during the disease - thalassaemia, unspecified
Thalassaemia is an inherited blood disorder caused by mutations in the genes that produce hemoglobin, the oxygen-carrying molecule in red blood cells. these mutations result in the production of an abnormal form of hemoglobin, which leads to a decrease in the number of red blood cells, resulting in anemia. the severity of the disorder depends on the type of mutation and the number of affected genes. in some cases, the disorder can be mild and require no treatment, while in others, it can be severe and require regular blood transfusions.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Hemoglobin Electrophoresis
- Iron Studies
- Alpha Thalassemia Genetic Testing
- Beta Thalassemia Genetic Testing
- Hemoglobin A2 (HbA2) Test
- Hemoglobin F (HbF) Test
- Red Blood Cell Indices
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of Thalassaemia, unspecified.
- Regular blood transfusions
- Iron chelation therapy
- Regular monitoring of blood counts
- Folic acid supplementation
- Vitamin B12 supplementation
- Regular monitoring of liver and spleen function
- Regular monitoring of growth and development
- Regular monitoring of nutritional status
7 Days of Hospitalization Required
83 Hours Required for Outpatient Treatment
Thalassaemia, unspecified - Prevention
The best way to prevent thalassaemia, unspecified, is to ensure that both parents are tested for the disease before attempting to conceive. if both parents are carriers, genetic counseling should be sought to determine the risk of having an affected child. additionally, women who are pregnant should be tested for thalassaemia, unspecified, and other genetic disorders.